Upload Avatar (500 x 500)
Dali Li
Life Science
East China Normal University
Shanghai
Language: English, Chinese
Genetic
Diseases
Gene
Therapy
Editing
Clinical
Research
Treatment
Innovation
Technology
Areas of Focus
- Genetic diseases
- Gene therapy
Work Experience
- 2009-2014 - East China Normal University, Life Sciences College, Promoted from Associate Professor to Researcher
- Current - Director at Shanghai Center for Gene Editing and Cell Therapy
- Current - Deputy Director at Shanghai Key Laboratory of Regulatory Biology
- Current - Director at East China Normal University Minhang Experimental Animal Center
Academic Background & Achievements
- 2007 - PhD in Genetics, Hunan Normal University
- Joint research at Texas A&M University during PhD
- Recipient of the 'Outstanding Youth Fund'
Publications
- Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL, Zhang J, Hu Y, Yang J, Li W, Zhang M, Wang Q, Zhang L, Wei G, Tian Y, Zhao K, Chen A, Tan B, Cui J, Li D, Li Y, Qi Y, Wang D, Wu Y, Li D, Du B, Liu M, Huang H, 2022
- CRISPR-Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia, Fu B, Liao J, Chen S, Li W, Wang Q, Hu J, Yang F, Hsiao S, Jiang Y, Wang L, Chen F, Zhang Y, Wang X, Li D, Liu M, Wu Y, 2022
Awards
- 2018 - First Prize in Natural Science Award from the Ministry of Education (Second Place)
- 2018 - Second Prize in Science and Technology Progress Award from Hainan Province (Fourth Place)
